NEW YORK (GenomeWeb News) – Decode Genetics has received notification from the Nasdaq Stock Market that the firm's common stock will be suspended from trading as of the open of business tomorrow.

The Iceland-based firm also said that documents will be filed with the US Securities and Exchange Commission, which will remove the firm's common stock from listing on Nasdaq.

Decode said that it is possible its stock will be traded thereafter on the Pink Sheets, but that depends if there is a market maker for the shares.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."